Skape Bio
PrivateLast Round
Pre Seed
Sep 22, 2025
Total Funding Raised
$1.27M
Company Overview
Skape Bio operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Pre Seed round in September 2025.
Skape Bio is a biotechnology company with a drug discovery platform designed for pharmaceutical companies to unlock G protein-coupled receptors. The company's AI-driven platform unites generative protein design, native receptor biology, and scalable in-cell screening, enabling drug developers to access unreachable therapeutic targets and achieve precise receptor modulation.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skape Bio Comparables
Compare Skape Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SelekTx | 82% | |
| VRG Therapeutics | 82% | |
| Fusiomica | 79% |
For institutional investors. Book with your work email.
Skape Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Skape Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mission BioCapital | Pre Seed |
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
$500K round led by Mission BioCapital
For institutional investors. Book with your work email.
Skape Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Skape Bio's valuation, stock price, and market status.
Is Skape Bio a public or private company?
Skape Bio is a private company.
What is the current stock price of Skape Bio?
Skape Bio is a private company, so its shares have no public market price. Caplight tracks Skape Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Skape Bio worth (valuation)?
Valuation information for Skape Bio is not publicly available.
Can I buy Skape Bio stock?
Skape Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Skape Bio's last funding round?
Skape Bio's most recent funding round was Pre Seed on September 22, 2025.
Who are the main investors in Skape Bio?
Key investors in Skape Bio include Mission BioCapital, BioInnovation Institute.
Will Skape Bio IPO soon?
No public IPO plans have been announced for Skape Bio.
How can I track Skape Bio secondary market activity?
Caplight tracks bids, offers, and trades in Skape Bio's shares on secondary markets.